Tagged infection
Press Release
MicroGenDX Next-Generation Sequencing PJI Study Named as JBJS Notable Article of 2022
The landmark 14-Site study on the role of Next-Generation Sequencing in Periprosthetic Joint Infections has been acknowledged by the journal as being one of the ten that "will have the greatest impact on patient care." Read More
Press Release
Ebola Detection Using Rapid Tests and ELISA Kits for Humans and Animals
Ebola detection kits for humans and animals are now possible using ADI antibody or antigen ELISA kits with results in less than 2 hours. Ebola Rapid test cards, similar to pregnancy tests, have also been developed that provide results in 2-10 mins. Read More
Press Release
Deadly Skin Infection NIghtmare Becomes Poignant Memoir
"A Plague of Boils" is one individual's short but powerful memoir on his fight to the death with a skin infection caused by ordinary "staph" bacteria - a germ that can literally be found on everyone's skin, all the time. Read More
Press Release
Semprus BioSciences Awarded $1 Million U.S. Army Grant to Develop "Anti-Biofilm Trauma Devices"
Semprus BioSciences today announced it has received a $1 million grant from the U.S. Army Telemedicine & Advanced Technology Research Center (TATRC) to develop the world's first orthopedic devices designed to reduce biofilm formation. Read More
Press Release
Encouraged by Early Clinical Studies, A Biotech Company Expands Its HIV/AIDS Vaccine Program
GeoVax has decided to expand its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) and the HIV Vaccine Trials Read More
Press Release
Novel Non-antibiotic Anti-infective Successfully Treats Impetigo Patients Including 100% Infected with MRSA
NovaBay Pharmaceuticals, Inc., is innovating a new class of drugs, known as Aganocide® compounds, that mimic the body's natural defense against infection. The Aganocides could potentially equal or exceed the utility of antibiotics. Read More
Press Release
PolyMedix Receives Phase 2 NIH Grant to Develop a Novel Antimicrobial Defensin Mimetic for Oral Candidiasis
PolyMedix, Inc, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis. Read More
Press Release
Novel Compound Found to Inhibit Biofilm Formation in Urinary Catheters
Over 300,000 patients suffering from stroke and multiple sclerosis or spinal cord injuries resulting in quadriplegia or paraplegia use Foley catheters. These patients are at a daily risk for developing catheter-associated urinary tract infections. Read More
Press Release